Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Howard Hughes Holdings Inc.HHH · Entity 4080 | Director · Chief Investment Officer | May 05, 2025 | May 15, 2025 |
| PERSHING SQUARE INC.PS · Entity 3337 | Director · Chief Investment Officer | April 28, 2026 | May 05, 2026 |
| Pershing Square USA, Ltd.PSUS · Entity 9114 | Chief Investment Officer | October 02, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Howard Hughes Holdings Inc.
Report date May 05, 2025 · Filed May 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 970 |
Reported balance
Holding disclosure · report date 2025-05-05 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 970 |
PERSHING SQUARE INC.
Report date April 28, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,144,214 |
Ending reported balance
After 2026-04-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-04-30 · Disposition to issuer · Disposed 667,614 · Balance 9,044,214 F1: On April 30, 2026, the Issuer and Pershing Square USA, Ltd. ("PSUS") completed a combined transaction, consisting of (i) an initial public offering (the "PS IPO") and a concurrent private placement of Issuer common stock and (ii) an initial public offering (the "PSUS IPO" and together with the PS IPO, the "combined IPO") and a concurrent private placement of PSUS's Common Shares of Beneficial Interest ("PSUS Common Shares") (collectively, the "combined transaction"). F2: Pursuant to the Amended and Restated Purchase Price Adjustment Agreement (the "A&R Purchase Price Adjustment Agreement") by and among the Issuer, Pershing Square Partner Group, LLC ("PSPG") and the other parties thereto (including the Reporting Person), PSPG and other parties thereto (including the Reporting Person) contributed Issuer common stock to the Issuer in an aggregate amount equal to the number of shares of Issuer common stock issued in connection with the combined transaction. Each party's contribution ("Purchase Price Adjustment Contribution") corresponds to such party's pro rata share of the aggregate number of shares of Issuer common stock held by the parties as of immediately prior to the completion of the combined transaction. Row 2 · 2026-04-30 · Other · Acquired 100,000 · Balance 9,144,214 F1: On April 30, 2026, the Issuer and Pershing Square USA, Ltd. ("PSUS") completed a combined transaction, consisting of (i) an initial public offering (the "PS IPO") and a concurrent private placement of Issuer common stock and (ii) an initial public offering (the "PSUS IPO" and together with the PS IPO, the "combined IPO") and a concurrent private placement of PSUS's Common Shares of Beneficial Interest ("PSUS Common Shares") (collectively, the "combined transaction"). F3: Reflects the acquisition of Issuer common stock in connection with the combined IPO. In connection with the PS IPO, each initial investor acquired 1 share of Issuer common stock for no additional consideration for every 5 PSUS Common Shares that the investor purchased in the PSUS IPO. |
| M Units of Pershing Square Partner Group, LLCSEC Table II · derivative / convertible security | Direct | 23,576,358 |
Reported balance
After 2026-04-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-28 · Grant · Acquired 23,576,358 · Balance 23,576,358 F4: These M Units ("M Units") of PSPG were granted to the Reporting Person pursuant to an amendment of PSPG's governing document on a pro rata basis of the Reporting Person's prior interest in PSPG on April 28, 2026. The M Units are unvested and subject to vesting and forfeiture. The standard vesting schedule for M Units provides for vesting (i) 6.25% each year during years 1 to 4, (ii) 8.33% each year during years 5 to 7, and (iii) 16.67% each year during years 8 to 10. The grant was approved by the board of directors of the Issuer in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F5: Upon vesting, each M Unit may be redeemed by the holder, subject to certain conditions, for shares of Issuer common stock held by PSPG on a one-for-one basis, subject to certain adjustments pursuant to the terms approved by the board of directors of the Issuer. These redemption rights do not expire. F6: Reflects the pro rata adjustment, pursuant to PSPG's governing document in connection with its Purchase Price Adjustment Contribution, of the number of shares of Issuer common stock for which each M unit may be redeemed. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 30, 2026, the Issuer and Pershing Square USA, Ltd. ("PSUS") completed a combined transaction, consisting of (i) an initial public offering (the "PS IPO") and a concurrent private placement of Issuer common stock and (ii) an initial public offering (the "PSUS IPO" and together with the PS IPO, the "combined IPO") and a concurrent private placement of PSUS's Common Shares of Beneficial Interest ("PSUS Common Shares") (collectively, the "combined transaction").
F2: Pursuant to the Amended and Restated Purchase Price Adjustment Agreement (the "A&R Purchase Price Adjustment Agreement") by and among the Issuer, Pershing Square Partner Group, LLC ("PSPG") and the other parties thereto (including the Reporting Person), PSPG and other parties thereto (including the Reporting Person) contributed Issuer common stock to the Issuer in an aggregate amount equal to the number of shares of Issuer common stock issued in connection with the combined transaction. Each party's contribution ("Purchase Price Adjustment Contribution") corresponds to such party's pro rata share of the aggregate number of shares of Issuer common stock held by the parties as of immediately prior to the completion of the combined transaction.
F3: Reflects the acquisition of Issuer common stock in connection with the combined IPO. In connection with the PS IPO, each initial investor acquired 1 share of Issuer common stock for no additional consideration for every 5 PSUS Common Shares that the investor purchased in the PSUS IPO.
F4: These M Units ("M Units") of PSPG were granted to the Reporting Person pursuant to an amendment of PSPG's governing document on a pro rata basis of the Reporting Person's prior interest in PSPG on April 28, 2026. The M Units are unvested and subject to vesting and forfeiture. The standard vesting schedule for M Units provides for vesting (i) 6.25% each year during years 1 to 4, (ii) 8.33% each year during years 5 to 7, and (iii) 16.67% each year during years 8 to 10. The grant was approved by the board of directors of the Issuer in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
F5: Upon vesting, each M Unit may be redeemed by the holder, subject to certain conditions, for shares of Issuer common stock held by PSPG on a one-for-one basis, subject to certain adjustments pursuant to the terms approved by the board of directors of the Issuer. These redemption rights do not expire.
F6: Reflects the pro rata adjustment, pursuant to PSPG's governing document in connection with its Purchase Price Adjustment Contribution, of the number of shares of Issuer common stock for which each M unit may be redeemed.
Pershing Square USA, Ltd.
Report date October 02, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares of Beneficial InterestSEC Table I · non-derivative | Direct | 756,613 |
Ending reported balance
After 2026-10-06 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-10-02 · Purchase · Acquired 78,138 · Balance 578,138 F1: Reflects the acquisition of the Issuer's Common Shares of Beneficial Interest through multiple open market transactions at prices ranging from $37.035 to $37.35, inclusive. F2: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. Row 2 · 2026-10-05 · Purchase · Acquired 120,816 · Balance 698,954 F2: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. F3: Reflects the acquisition of the Issuer's Common Shares of Beneficial Interest through multiple open market transactions at prices ranging from $37.115 to $37.70, inclusive. Row 3 · 2026-10-06 · Purchase · Acquired 57,659 · Balance 756,613 F2: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. F4: Reflects the acquisition of the Issuer's Common Shares of Beneficial Interest through multiple open market transactions at prices ranging from $37.50 to $38.15, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the acquisition of the Issuer's Common Shares of Beneficial Interest through multiple open market transactions at prices ranging from $37.035 to $37.35, inclusive.
F2: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.
F3: Reflects the acquisition of the Issuer's Common Shares of Beneficial Interest through multiple open market transactions at prices ranging from $37.115 to $37.70, inclusive.
F4: Reflects the acquisition of the Issuer's Common Shares of Beneficial Interest through multiple open market transactions at prices ranging from $37.50 to $38.15, inclusive.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Element Solutions Inc
Report date February 04, 2019 · Filed February 04, 2019
Section 16 reporting ended · disclosed 2019-02-04. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2026 Filed Oct 6, 2026 21:59 UTC | Pershing Square USA, Ltd. PSUS · Entity 9114 | PurchaseCommon Shares of Beneficial Interest | 57,659 | $37.87 | $2,183,759.67 |
DisclosureSEC source: 0001193125-26-415861 · ownership.xml · nonDerivative · entry 3 ISRAEL RYAN · CIK 0001597463 · Chief Investment Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 756,613 F2 · kind: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. F4 · kind: Reflects the acquisition of the Issuer's Common Shares of Beneficial Interest through multiple open market transactions at prices ranging from $37.50 to $38.15, inclusive. Read SEC document |
| October 05, 2026 Filed Oct 6, 2026 21:59 UTC | Pershing Square USA, Ltd. PSUS · Entity 9114 | PurchaseCommon Shares of Beneficial Interest | 120,816 | $37.45 | $4,524,003.45 |
DisclosureSEC source: 0001193125-26-415861 · ownership.xml · nonDerivative · entry 2 ISRAEL RYAN · CIK 0001597463 · Chief Investment Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 698,954 F2 · kind: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. F3 · kind: Reflects the acquisition of the Issuer's Common Shares of Beneficial Interest through multiple open market transactions at prices ranging from $37.115 to $37.70, inclusive. Read SEC document |
| October 02, 2026 Filed Oct 6, 2026 21:59 UTC | Pershing Square USA, Ltd. PSUS · Entity 9114 | PurchaseCommon Shares of Beneficial Interest | 78,138 | $37.21 | $2,907,452.47 |
DisclosureSEC source: 0001193125-26-415861 · ownership.xml · nonDerivative · entry 1 ISRAEL RYAN · CIK 0001597463 · Chief Investment Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 578,138 F1 · kind: Reflects the acquisition of the Issuer's Common Shares of Beneficial Interest through multiple open market transactions at prices ranging from $37.035 to $37.35, inclusive. F2 · kind: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. Read SEC document |
| April 30, 2026 Filed May 1, 2026 20:30 UTC | Pershing Square USA, Ltd. PSUS · Entity 9114 | PurchaseCommon Shares of Beneficial Interest | 500,000 | $50.00 | $25,000,000.00 |
DisclosureSEC source: 0001140361-26-018580 · form4.xml · nonDerivative · entry 1 ISRAEL RYAN · CIK 0001597463 · Chief Investment Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 F1 · kind: On April 30, 2026, Pershing Square Inc. ("PS") and the Issuer completed a combined transaction, consisting of (i) an initial public offering and a concurrent private placement of PS common stock and (ii) an initial public offering (the "PSUS IPO") and a concurrent private placement of the Issuer's Common Shares of Beneficial Interest ("Common Shares"). F2 · kind: Reflects the acquisition of Issuer Common Shares on April 30, 2026 in the PSUS IPO. Read SEC document |
| April 30, 2026 Filed May 5, 2026 00:44 UTC | PERSHING SQUARE INC. PS · Entity 3337 | OtherCommon Stock | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-26-018951 · form4.xml · nonDerivative · entry 2 ISRAEL RYAN · CIK 0001597463 · Director · Chief Investment Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,144,214 F1 · kind: On April 30, 2026, the Issuer and Pershing Square USA, Ltd. ("PSUS") completed a combined transaction, consisting of (i) an initial public offering (the "PS IPO") and a concurrent private placement of Issuer common stock and (ii) an initial public offering (the "PSUS IPO" and together with the PS IPO, the "combined IPO") and a concurrent private placement of PSUS's Common Shares of Beneficial Interest ("PSUS Common Shares") (collectively, the "combined transaction"). F3 · kind: Reflects the acquisition of Issuer common stock in connection with the combined IPO. In connection with the PS IPO, each initial investor acquired 1 share of Issuer common stock for no additional consideration for every 5 PSUS Common Shares that the investor purchased in the PSUS IPO. F3 · price: Reflects the acquisition of Issuer common stock in connection with the combined IPO. In connection with the PS IPO, each initial investor acquired 1 share of Issuer common stock for no additional consideration for every 5 PSUS Common Shares that the investor purchased in the PSUS IPO. Read SEC document |
| April 30, 2026 Filed May 5, 2026 00:44 UTC | PERSHING SQUARE INC. PS · Entity 3337 | Disposition to issuerCommon Stock | 667,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-018951 · form4.xml · nonDerivative · entry 1 ISRAEL RYAN · CIK 0001597463 · Director · Chief Investment Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,044,214 F1 · kind: On April 30, 2026, the Issuer and Pershing Square USA, Ltd. ("PSUS") completed a combined transaction, consisting of (i) an initial public offering (the "PS IPO") and a concurrent private placement of Issuer common stock and (ii) an initial public offering (the "PSUS IPO" and together with the PS IPO, the "combined IPO") and a concurrent private placement of PSUS's Common Shares of Beneficial Interest ("PSUS Common Shares") (collectively, the "combined transaction"). F2 · kind: Pursuant to the Amended and Restated Purchase Price Adjustment Agreement (the "A&R Purchase Price Adjustment Agreement") by and among the Issuer, Pershing Square Partner Group, LLC ("PSPG") and the other parties thereto (including the Reporting Person), PSPG and other parties thereto (including the Reporting Person) contributed Issuer common stock to the Issuer in an aggregate amount equal to the number of shares of Issuer common stock issued in connection with the combined transaction. Each party's contribution ("Purchase Price Adjustment Contribution") corresponds to such party's pro rata share of the aggregate number of shares of Issuer common stock held by the parties as of immediately prior to the completion of the combined transaction. Read SEC document |
| April 28, 2026 Filed May 5, 2026 00:44 UTC | PERSHING SQUARE INC. PS · Entity 3337 | GrantM Units of Pershing Square Partner Group, LLC · Derivative | 23,576,358 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-26-018951 · form4.xml · derivative · entry 3 ISRAEL RYAN · CIK 0001597463 · Director · Chief Investment Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,576,358 Underlying: Common Stock · 21,955,663 shares Expires not disclosed F4 · derivative.exercise_price: These M Units ("M Units") of PSPG were granted to the Reporting Person pursuant to an amendment of PSPG's governing document on a pro rata basis of the Reporting Person's prior interest in PSPG on April 28, 2026. The M Units are unvested and subject to vesting and forfeiture. The standard vesting schedule for M Units provides for vesting (i) 6.25% each year during years 1 to 4, (ii) 8.33% each year during years 5 to 7, and (iii) 16.67% each year during years 8 to 10. The grant was approved by the board of directors of the Issuer in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_price: Upon vesting, each M Unit may be redeemed by the holder, subject to certain conditions, for shares of Issuer common stock held by PSPG on a one-for-one basis, subject to certain adjustments pursuant to the terms approved by the board of directors of the Issuer. These redemption rights do not expire. F6 · derivative.exercise_price: Reflects the pro rata adjustment, pursuant to PSPG's governing document in connection with its Purchase Price Adjustment Contribution, of the number of shares of Issuer common stock for which each M unit may be redeemed. F4 · price: These M Units ("M Units") of PSPG were granted to the Reporting Person pursuant to an amendment of PSPG's governing document on a pro rata basis of the Reporting Person's prior interest in PSPG on April 28, 2026. The M Units are unvested and subject to vesting and forfeiture. The standard vesting schedule for M Units provides for vesting (i) 6.25% each year during years 1 to 4, (ii) 8.33% each year during years 5 to 7, and (iii) 16.67% each year during years 8 to 10. The grant was approved by the board of directors of the Issuer in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F5 · price: Upon vesting, each M Unit may be redeemed by the holder, subject to certain conditions, for shares of Issuer common stock held by PSPG on a one-for-one basis, subject to certain adjustments pursuant to the terms approved by the board of directors of the Issuer. These redemption rights do not expire. F6 · price: Reflects the pro rata adjustment, pursuant to PSPG's governing document in connection with its Purchase Price Adjustment Contribution, of the number of shares of Issuer common stock for which each M unit may be redeemed. F4 · derivative.exercise_date: These M Units ("M Units") of PSPG were granted to the Reporting Person pursuant to an amendment of PSPG's governing document on a pro rata basis of the Reporting Person's prior interest in PSPG on April 28, 2026. The M Units are unvested and subject to vesting and forfeiture. The standard vesting schedule for M Units provides for vesting (i) 6.25% each year during years 1 to 4, (ii) 8.33% each year during years 5 to 7, and (iii) 16.67% each year during years 8 to 10. The grant was approved by the board of directors of the Issuer in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: Upon vesting, each M Unit may be redeemed by the holder, subject to certain conditions, for shares of Issuer common stock held by PSPG on a one-for-one basis, subject to certain adjustments pursuant to the terms approved by the board of directors of the Issuer. These redemption rights do not expire. F6 · derivative.exercise_date: Reflects the pro rata adjustment, pursuant to PSPG's governing document in connection with its Purchase Price Adjustment Contribution, of the number of shares of Issuer common stock for which each M unit may be redeemed. F4 · derivative.expiration_date: These M Units ("M Units") of PSPG were granted to the Reporting Person pursuant to an amendment of PSPG's governing document on a pro rata basis of the Reporting Person's prior interest in PSPG on April 28, 2026. The M Units are unvested and subject to vesting and forfeiture. The standard vesting schedule for M Units provides for vesting (i) 6.25% each year during years 1 to 4, (ii) 8.33% each year during years 5 to 7, and (iii) 16.67% each year during years 8 to 10. The grant was approved by the board of directors of the Issuer in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F5 · derivative.expiration_date: Upon vesting, each M Unit may be redeemed by the holder, subject to certain conditions, for shares of Issuer common stock held by PSPG on a one-for-one basis, subject to certain adjustments pursuant to the terms approved by the board of directors of the Issuer. These redemption rights do not expire. F6 · derivative.expiration_date: Reflects the pro rata adjustment, pursuant to PSPG's governing document in connection with its Purchase Price Adjustment Contribution, of the number of shares of Issuer common stock for which each M unit may be redeemed. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.